WAVE Life Sciences (WVE) Misses Q2 EPS by 4c

WAVE Life Sciences (NASDAQ: WVE) reported Q2 EPS of ($0.31), $0.04 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $8.7 million versus the consensus estimate of $14.31 million.

For earnings history and earnings-related data on WAVE Life Sciences (WVE) click here.

You May Also Be Interested In

• Travere Therapeutics (TVTX) PT Raised to $65 at Guggenheim
• Qualcomm (QCOM) PT Raised to $235 at UBS: 'FY29 Target Model Revs Largely in Line'
• SYNNEX Corp. (SNX) Tops Q2 EPS by 74c, Beats on Revenue; Offers Q3 Guidance